Thrombomodulin Alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameThrombomodulin Alfa
Drug Alias Namerhs-TM血栓调节素αRecombinant human soluble thrombomodulin凝血调节蛋白α血栓调节蛋白α +[18] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProthrombin inhibitorsVitamin K-dependent protein C inhibitors
TargetsVitamin K-dependent protein CProthrombin
Therapy Area/IndicationsDisseminated Intravascular CoagulationBlood Coagulation DisordersPeripheral Nervous System Diseases +[6] 
Global Approved IndicationsDisseminated Intravascular Coagulation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2008/01/25
Country/TerritoryCzechiaBelgiumBulgaria +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Corp
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Corp
Inactive CompaniesArtisan Pharma IncVeloxis PharmaceuticalsAsahi Kasei Pharma America Corp
Active IndicationsDisseminated Intravascular Coagulation
Inactive IndicationsBlood Coagulation DisordersPeripheral Nervous System DiseasesIdiopathic Pulmonary Fibrosis +[5] 

Other Information

ATC CodeB01AX
Related LinksDrugBankKEGG